ELI LILLY & CO (LLY)
Clinical trial NCT04106219 updates: 1. completion date: 2026-08-01 → 2027-08-01 2. collaborators added: New Approaches to Neuroblastoma Therapy Consortium 3. collaborators removed: New Approaches to Neuroblastoma Therapy Consortium (NANT)
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical